Benzinga Rankings give you vital metrics on any stock – anytime.
Explore Emergent BioSolutions stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for EBS.
You can purchase shares of Emergent BioSolutions (NYSE:EBS) through any online brokerage.
Other companies in Emergent BioSolutions’s space includes: Humacyte (NASDAQ:HUMA), Monopar Therapeutics (NASDAQ:MNPR), aTyr Pharma (NASDAQ:ATYR), Olema Pharmaceuticals (NASDAQ:OLMA) and Monte Rosa Therapeutics (NASDAQ:GLUE).
Emergent BioSolutions has a consensus price target of $25.86.
The stock price for Emergent BioSolutions (NYSE: EBS) is $4.5501 last updated April 15, 2025 at 7:44 PM EDT.
There are no upcoming dividends for Emergent BioSolutions.
Emergent BioSolutions’s Q1 earnings are confirmed for Wednesday, April 30, 2025.
There is no upcoming split for Emergent BioSolutions.
Emergent BioSolutions is in the Health Care sector and Biotechnology industry. They are listed on the NYSE.